Back
Elite Pharmaceuticals, Inc. 10K Form
Sell
15
ELTP
Elite Pharmaceuticals, Inc.
Last Price:
$0.38
Seasonality Move:
30.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-16 | 10Q | ELTP/Elite Pharmaceuticals, Inc. Quarterly |
| 2020-11-16 | 10Q | ELTP/Elite Pharmaceuticals, Inc. Quarterly |
| 2020-08-14 | 10Q | ELTP/Elite Pharmaceuticals, Inc. Quarterly |
| 2020-06-29 | 10K | ELTP/Elite Pharmaceuticals, Inc. Annual |
| 2020-02-10 | 10Q | ELTP/Elite Pharmaceuticals, Inc. Quarterly |
| 2019-11-12 | 10Q | ELTP/Elite Pharmaceuticals, Inc. Quarterly |
Receive ELTP News And Ratings
See the #1 stock for the next 7 days that we like better than ELTP
ELTP Financial Statistics
Sales & Book Value
| Annual Sales: | $84M |
|---|---|
| Cash Flow: | $-5.5M |
| Price / Cash Flow: | 25.07 |
| Annual Sales: | $0.07 |
| Price / Book: | 5.25 |
Profitability
| EPS (TTM): | 0.02170 |
|---|---|
| Net Income (TTM): | $43.4M |
| Gross Margin: | $38.4M |
| Return on Equity: | 77.64% |
| Return on Assets: | 40.04% |
Elite Pharmaceuticals, Inc. Earnings Forecast
Key Elite Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for ELTP is 45.69%.
-
The Selling, General & Administrative Expenses for ELTP have been equal to 10.71% of Gross Profit Margin.
-
The Research & Development expenses have been 9.48% of Revenue.
-
The Net Earning history of ELTP is -5.13% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 11 years.
Elite Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ELTP |
| Website: | elitepharma.com |
Debt
| Debt-to-Equity Ratio: | 0.08 |
|---|---|
| Current Ratio: | 7.34 |
| Quick Ratio: | 5.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 36.6 |
|---|---|
| Forward P/E Ratio: | 0 |
ELTP Technical Analysis vs Fundamental Analysis
Sell
15
Elite Pharmaceuticals, Inc. (ELTP)
is a Sell
Is Elite Pharmaceuticals, Inc. a Buy or a Sell?
-
Elite Pharmaceuticals, Inc. stock is rated a SellThe current Elite Pharmaceuticals, Inc. [ELTP] share price is $0.39. The Score for ELTP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.